We are live on
!
Find out more
SELLAS Life Sciences
11 hedge funds and large institutions have $1.67M invested in SELLAS Life Sciences in 2019 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
50% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 2
7.87% more ownership
Funds ownership: 0.12% → 7.99% (+7.9%)
5% more capital invested
Capital invested by funds: $1.6M → $1.67M (+$74K)
39% less funds holding
Funds holding: 18 → 11 (-7)
58% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 12
Holders
11
Holders Change
-7
Holders Change %
-38.89%
% of All Funds
0.22%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
3
Reduced
2
Closed
12
Calls
$269K
Puts
–
Net Calls
+$269K
Net Calls Change
+$261K
Top Buyers
| 1 |
BlackRock
New York
|
+$529K |
| 2 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
+$222K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$153K |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
+$64.1K |
| 5 |
WG
Winton Group
London,
United Kingdom
|
+$59.5K |
Top Sellers
| 1 |
6CM
683 Capital Management
New York
|
-$400K |
| 2 |
Renaissance Technologies
New York
|
-$17K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$15K |
| 4 |
Jane Street
New York
|
-$10K |
| 5 |
MML Investors Services
Springfield,
Massachusetts
|
-$8K |
